Cytokinetics, Incorporated · NASDAQ:CYTK
T. Rowe Price Investment Management, Inc. reported a 14.50% stake in Cytokinetics, Incorporated (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
T. Rowe Price Investment Management, Inc. reported a 14.50% stake in Cytokinetics, Incorporated, 17,716,372 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 14.50%
- Shares
- 17,716,372
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14.50% | 17,716,372 |
Source
Related
- Cytokinetics, Incorporated
- T. Rowe Price Investment Management, Inc.
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 14, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2025
- Schedule 13G · T. Rowe Price Investment Management, Inc. · May 7, 2025
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026